By IDSE News Staff
A new antiretroviral drug, dolutegravir (Tivicay, ViiV Healthcare), can reduce the HIV viral load in semen, an area of the body considered to be a reservoir of the virus and where access for drugs is more difficult (J Infect Dis 2016 Nov 22. [Epub ahead of print]).
The study results show the potential of these new treatments to reduce the chances of sexual transmission of the virus, according to researchers from the Infections of the Respiratory Tract and in Immunocompromised